These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26205548)

  • 1. Recent advances in potential treatment of diabetes and diabetic vascular complications by bioactive natural products and new synthetic compounds.
    Gendaszewska-Darmach E
    Curr Top Med Chem; 2015; 15(23):2341. PubMed ID: 26205548
    [No Abstract]   [Full Text] [Related]  

  • 2. Gymnema sylvestre for Diabetes: From Traditional Herb to Future's Therapeutic.
    Tiwari P; Ahmad K; Baig MH
    Curr Pharm Des; 2017; 23(11):1667-1676. PubMed ID: 27834124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in the use of oral hypoglycaemic agents in diabetes mellitus-practical therapeutics.
    Obel AO
    East Afr Med J; 1981 Apr; 58(4):244-8. PubMed ID: 7261976
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of post prandial blood glucose levels with oral G.T.T. values as a parameter for control of diabetes mellitus and its influence on vascular complications.
    Dhirawani MK; Deoda KM; Patel JC
    Indian J Med Sci; 1970 Apr; 24(4):181-90. PubMed ID: 5505594
    [No Abstract]   [Full Text] [Related]  

  • 5. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications.
    Chen J; Mangelinckx S; Adams A; Wang ZT; Li WL; De Kimpe N
    Nat Prod Commun; 2015 Jan; 10(1):187-200. PubMed ID: 25920244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
    Vázquez MC; Sobrevia L
    Curr Vasc Pharmacol; 2019; 17(5):429-431. PubMed ID: 31418345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of patients with diabetes and diabetic angiopathies of the lower extremities with butylbiguanide (Silubin retard)].
    Tikholov K
    Ter Arkh; 1974; 46(1):111-3. PubMed ID: 4453970
    [No Abstract]   [Full Text] [Related]  

  • 10. [Geriatric aspects of diabetes mellitus and diabetic angiopathies].
    Efimov ES
    Ter Arkh; 1983; 55(12):64-6. PubMed ID: 6665721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutics in diabetology].
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():315-23. PubMed ID: 7401428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some opinions on the integrative Chinese and Western medical study of diabetes mellitus].
    Lin L; Ni Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Nov; 23(11):855-7. PubMed ID: 14666771
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural Products Modulating Autophagy Pathway Against the Pathogenesis of Diabetes Mellitus.
    Li L; Qi J; Li H
    Curr Drug Targets; 2019; 20(1):96-110. PubMed ID: 30047328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients.
    Yaribeygi H; Butler AE; Barreto GE; Sahebkar A
    J Cell Physiol; 2019 Mar; 234(3):2436-2446. PubMed ID: 30191997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of metabolic mischief--meritorious or meretricious?
    Service FJ
    Endocr Pract; 2003; 9(1):101-2. PubMed ID: 12917099
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary hydroxyproline excretion in diabetes mellitus].
    Lohmann D; Schallawitz R; Schallawitz S
    Z Gesamte Inn Med; 1970 Aug; 25(15):700-4. PubMed ID: 5527535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current problems in the oral therapy of diabetes mellitus].
    Lubetzki J; Warnet A
    Therapie; 1979; 34(5):539-53. PubMed ID: 398082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes. A daily problem: glycemic equilibrium. A long term problem: vascular complications. Discussion].
    Sem Hop Ther; 1973 Sep; 49 Spec No():111-5. PubMed ID: 4804046
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelial dysfunction, inflammation and diabetes.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P
    Rev Endocr Metab Disord; 2004 Aug; 5(3):189-97. PubMed ID: 15211090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.